SELEGILINE IN THE TREATMENT OF BEHAVIOUR
β
BRIAN A. LAWLOR; PAUL S. AISEN; CYNTHIA GREEN; ELIZABETH FINE; JAMES SCHMEIDLER
π
Article
π
1997
π
John Wiley and Sons
π
English
β 97 KB
π 2 views
Objective. The purpose of this study was to examine the behavioural and cognitive eects of selegiline in a group of moderately behaviourally disturbed AD patients. Design. This was a 14-week randomized double-blind placebo-controlled study of selegiline (10 mg) and placebo. Setting. An outpatient